Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells.

Translated title of the contribution: Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells.

M.D. Wissing, J. Mendonca, E. Kim, E Kim, J.S. Shim, N.S. Kaelber, H. Kant, H. Hammers, T. Commes, P.J. van Diest, J.O. Liu, S.K. Kachhap

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionIdentification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells.
Original languageUndefined/Unknown
Pages (from-to)401-410
Number of pages10
JournalCancer Biology & Therapy
Volume14
Issue number5
Publication statusPublished - 2013

Cite this